SCHEMBL7794971

SCHEMBL7794971

CCOC(=O)/C=C/c1cnc(SC)nc1N(C)C[C@H](C)O

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 3/20 0.36
CNKSR1 Q969H4 1/20 0.36
CA12 O43570 1/20 0.36
CA1 P00915 1/20 0.36
CA2 P00918 1/20 0.36
CA7 P43166 1/20 0.36
CA9 Q16790 1/20 0.36
CA14 Q9ULX7 1/20 0.36
MEN1 O00255 2/20 0.35
KMT2A Q03164 2/20 0.35
SYK P43405 2/20 0.35
CCNC P24863 2/20 0.35
CDK8 P49336 2/20 0.35
POLB P06746 2/20 0.35
TDP1 Q9NUW8 1/20 0.35
CYP3A4 P08684 1/20 0.35
DPP4 P27487 2/20 0.34
TTR P02766 1/20 0.34
MAPT P10636 2/20 0.34
SMN1; SMN2 Q16637 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8373630 0.86 ALDH1A1 (0.38) ALDH1A1CNKSR1CA12CA1CA2
SCHEMBL7795394 0.79 ALDH1A1 (0.44) ALDH1A1CNKSR1CA12CA1CA2
SCHEMBL10192546 0.76 CNKSR1 (0.44) ALDH1A1CNKSR1CA12CA1CA2
SCHEMBL30509249 0.76 CNKSR1 (0.44) ALDH1A1CNKSR1CA12CA1CA2
SCHEMBL4711384 0.76 CNKSR1 (0.44) ALDH1A1CNKSR1CA12CA1CA2
SCHEMBL23266642 0.76 MEN1 (0.44) ALDH1A1CNKSR1CA12CA1CA2
SCHEMBL31521738 0.76 CNKSR1 (0.44) ALDH1A1CNKSR1CA12CA1CA2
SCHEMBL10192488 0.75 ALDH1A1 (0.46) ALDH1A1CNKSR1CA12CA1CA2
SCHEMBL4714245 0.75 ALDH1A1 (0.46) ALDH1A1CNKSR1CA12CA1CA2
SCHEMBL4713624 0.74 ALDH1A1 (0.48) ALDH1A1CNKSR1CA12CA1CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8404695-B2 Pyrimidinyl pyridone inhibitors of JNK ROCHE PALO ALTO LLC (US) 2013-03-26 US disclosed
US-8404695-B2 Pyrimidinyl pyridone inhibitors of JNK ROCHE PALO ALTO LLC (US) 2013-03-26 US disclosed
WO-2010046273-A2 PYRIMIDINYL PYRIDONE INHIBITORS OF JNK F. HOFFMANN-LA ROCHE AG (CH) 2010-04-29 WO disclosed
US-20100099691-A1 PYRIMIDINYL PYRIDONE INHIBITORS OF JNK ROCHE PALO ALTO LLC 2010-04-22 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100099691-A1 PYRIMIDINYL PYRIDONE INHIBITORS OF JNK MAP3K20, MAP3K6, MAP3K1 ALDH1A1 2056/4885CNKSR1 35/4885CA12 4880/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.